SCOTTSDALE, Ariz., February 12, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company focused on prescription Medical Foods, today announced that Danilo Casadei Massari, the founder of CM&D Pharma recently acquired by Nestle, has joined Prismic’s Management Team and Board of Directors.
Casadei Massari, who has an outstanding reputation as a successful healthcare entrepreneur, becomes President Europe with additional responsibility for worldwide corporate development. He has also been elected to the company’s Board of Directors.
Commenting on this significant development, Peter Moriarty, CEO and Chairman of the Board of Directors, stated, “Danilo has been involved in the founding and development of a number of very successful companies in the pharmaceutical and healthcare arenas. His venture prior to Prismic was CM&D Pharma, a European-based company also focused on prescription Medical Foods. CM&D Pharma was the first acquisition made by Nestle Health Science, a company established by Nestle in 2011 to create a new market between Food and Pharmaceuticals.”
Danilo Casadei Massari added that “Prismic is developing an extremely interesting portfolio. These are all IP protected, science-based products that are safe and effective, and can be expeditiously brought to market as prescription Medical Foods. One or two of these are also being evaluated as potential NDA candidates based on clinical data we have seen so far. Our focus is on products that can cost-effectively address commonly occurring disorders in the aging “baby boomer” population, and especially those where inflammation is an underlying cause.”
In summing-up, Peter Moriarty stated, “This is another major step-forward for Prismic, especially as we have also recently completed our initial round of equity funding which was significantly over-subscribed.”
About Prismic Pharmaceuticals, Inc. Prismic Pharmaceuticals, Inc., is a privately held pharmaceutical company focused on the development and marketing of prescription medical foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved. The company, founded in 2011, is headquartered in Scottsdale, Arizona, with offices in Boston, USA, and London, England. Contact 480.422.1810 or visit www.PrismicPharma.com
INFORMATION CONTACT Peter Moriarty Tel: 480.422.1810
SOURCE Prismic Pharmaceuticals, Inc.
